Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Report forecasts huge increase in veterinary medicine market
The global veterinary medicine market is expected to grow at a rate of 8.1 per cent over the next five years.
Increase in popularity of companion animals a key driver 

The global veterinary medicine market is expected to grow at a rate of 8.1 per cent over the next five years, according to a report published by marketresearchfuture.com

The Veterinary Medicine Market Report - Global Forecast to 2023 found that an increase in popularity of companion animals will be the biggest driver of the market. Increasing animal diseases and government welfare initiatives are also expected to provide a significant boost.

Veterinary medicine is widely practised across the globe due to an increasing number of pet adoptions, rising veterinary expenditure and rising demand for pet insurance. Some of the key players include Zoetis, Inc, Eli Lilly and Company and Bayer Healthcare AG.

The veterinary medicines market is segmented into five regions - America, Europe, Asia Pacific, the Middle East and Africa. America dominates the global medicines market due to the amount it spends on animal welfare and research in the veterinary market.

The report found that a high concentration of the major veterinary hospitals in the developed countries of the Americas - together with good reimbursement rates - are fuelling market growth. It also cites the high buying power of large healthcare players in the US as another major driving force.

In Europe, the second largest market in the world, market growth is led by Germany and France. The report forecasts that Germany will be the fastest growing market over the assessment period owing to its enormous pharmaceutical industry.

Animal-favoured government policies and tax benefits are also major driving forces in the European market, the report notes.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."